PDE4A and central nervous system disorder: Additionally, a recent study demonstrated that the PDE4 inhibitor apremilast suppressed MAPK and PI3K-mTOR signaling by reducing the expression of chemokines and chemokine receptors in the colon, indicating that PDE4 plays a role in peripheral system disorders besides its role in CNS disorders [93].